Amniotics AB engages in the development and manufacture biotechnology products. It harvests and propagates tissue from neonatal mesenchymal stem cells for regenerative medicine. The company was founded by Marcus Kåre Torleif Larsson, Nils Walter Andreas Herbst, and Niels-Bjarne Roland Woods on August 24, 2015 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company